Literature DB >> 11242406

Breast cancer prevention study aims to overcome drug bias.

B Vastag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11242406

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

Review 1.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs.

Authors:  Scott D Halpern; Peter A Ubel; Jesse A Berlin; Raymond R Townsend; David A Asch
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.